Literature DB >> 8900072

Adaptive surface antigen variation in Mycoplasma bovis to the host immune response.

D Le Grand1, M Solsona, R Rosengarten, F Poumarat.   

Abstract

The variability of predominant Mycoplasma bovis surface antigens in the presence of specific immune pressure was analyzed in an in vitro assay to determine if M. bovis could escape immune destruction. We have shown that serum antibodies from immunized or experimentally infected calves and monoclonal antibodies which specifically react with previously characterized or as yet undefined major M. bovis membrane surface proteins cause repression of expression or shortening of the target protein, or induce switching to expression of an antigenically distinct variant protein. We have further demonstrated that removal of the inducing antibody results in reversion to the original phenotype. These results suggest that the level of expression and the length of M. bovis surface antigens in the host is modulated by cognate antibodies. According to the surface antigenic variation systems, random selection of preexisting variants resistant to antibody-mediated inhibition or direct regulation of gene expression may be means by which this organism evades host immune defences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900072     DOI: 10.1111/j.1574-6968.1996.tb08540.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  Variable surface protein Vmm of Mycoplasma mycoides subsp. mycoides small colony type.

Authors:  Anja Persson; Karin Jacobsson; Lars Frykberg; Karl-Erik Johansson; François Poumarat
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

Review 2.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

3.  Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins.

Authors:  K Sachse; J H Helbig; I Lysnyansky; C Grajetzki; W Müller; E Jacobs; D Yogev
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Development of a recombinant antigen for antibody-based diagnosis of Mycoplasma bovis infection in cattle.

Authors:  M Brank; D Le Grand; F Poumarat; P Bezille; R Rosengarten; C Citti
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Role of the coypu (Myocastor coypus) in the epidemiology of leptospirosis in domestic animals and humans in France.

Authors:  V Michel; N Ruvoen-Clouet; A Menard; C Sonrier; C Fillonneau; F Rakotovao; J P Ganière; G André-Fontaine
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity.

Authors:  O Neyrolles; I Chambaud; S Ferris; M C Prevost; T Sasaki; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.

Authors:  C Citti; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

8.  Prevalence of Mycoplasma bovis in Algeria and Characterisation of the Isolated Clones.

Authors:  Yasmine Oucheriah; Nouzha Heleili; Adélie Colin; Catherine Mottet; Florence Tardy; Claire A M Becker
Journal:  Front Vet Sci       Date:  2022-05-20

9.  Chronic pneumonia in calves after experimental infection with Mycoplasma bovis strain 1067: characterization of lung pathology, persistence of variable surface protein antigens and local immune response.

Authors:  Kathrin Hermeyer; Inka Buchenau; Anne Thomasmeyer; Berit Baum; Joachim Spergser; Renate Rosengarten; Marion Hewicker-Trautwein
Journal:  Acta Vet Scand       Date:  2012-02-04       Impact factor: 1.695

10.  Molecular cloning and characterization of a surface-localized adhesion protein in Mycoplasma bovis Hubei-1 strain.

Authors:  Xiaohui Zou; Yuan Li; Yang Wang; Yumei Zhou; Yang Liu; Jiuqing Xin
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.